Owing to the intricate biochemical interconnections and the difference in biological pathway modulation between the peptides and the classical drugs that, in order to explore strategies to overcome tumour drug resistance and achieve greater therapeutic gains, the present in vitro study has investigated the effects of combining the novel TS inhibitor peptides with cDDP [1], as well as some classical antifolate agents. Here, TYMS is linked to neoplasm.